Moolec Science S.A. (MLEC) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Luxembourg, Luxembourg. The current CEO is Alejandro Antalich.
MLEC has IPO date of 2021-03-02, 52 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $5.38M.
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
